Bull
$4.63
Scenario price
$0.950
-0.005 (-0.51%)At close
Solesence, Inc., formerly Nanophase Technologies Corporation, provides healthcare solutions across beauty and life science categories. It is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The Company partners with global and indie brands, leveraging its proprietary Active Stress Defense technology suite (Original Active Stress Defense, Kleair, and Bloom) to bring environmental protection beauty products to market via over a dozen market-ready offerings that embrace self-expression, health care, and self-care across skin care and color cosmetic categories. It also offers custom development, with turnkey options available across all paths to market. The Company’s products are formulated using its own mineral sunscreen actives, which are produced in its Chicagoland facility where it has been producing sunscreen actives, including the zinc oxide sunscreen active.
Solesence, Inc. is currently trading at $0.95, with a forward P/E of 11.36, indicating potential undervaluation. However, the company has a significant year-to-date change of -36.67% and a one-year change of -73.83%, reflecting ongoing profitability challenges. The recent earnings report showed a net loss of $0.76 million in Q1 2026, which raises concerns about its financial stability. The RSI is at 47.23, suggesting it is neither overbought nor oversold, indicating a neutral technical position. Given these factors, it may be wise to hold rather than buy at this time, as the risks outweigh the potential rewards.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Solesence Inc Projects Strong Revenue Growth for 2026

Solésence Reschedules Q2 2026 Conference Call

Solésence's Day Mode Hero Concealer Wins Multiple Awards

UK Calls for National UV Safety Strategy

Solesence Q1 2026 Earnings Call Insights
Solesence, Inc., formerly Nanophase Technologies Corporation, provides healthcare solutions across beauty and life science categories. It is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The Company partners with global and indie brands, leveraging its proprietary Active Stress Defense technology suite (Original Active Stress Defense, Kleair, and Bloom) to bring environmental protection beauty products to market via over a dozen market-ready offerings that embrace self-expression, health care, and self-care across skin care and color cosmetic categories. It also offers custom development, with turnkey options available across all paths to market. The Company’s products are formulated using its own mineral sunscreen actives, which are produced in its Chicagoland facility where it has been producing sunscreen actives, including the zinc oxide sunscreen active. It operates in the Consumer Non-Cyclicals sector.
Solesence, Inc. is currently trading at $0.95, with a forward P/E of 11.36, indicating potential undervaluation. However, the company has a significant year-to-date change of -36.67% and a one-year change of -73.83%, reflecting ongoing profitability challenges. The recent earnings report showed a net loss of $0.76 million in Q1 2026, which raises concerns about its financial stability. The RSI is at 47.23, suggesting it is neither overbought nor oversold, indicating a neutral technical position. Given these factors, it may be wise to hold rather than buy at this time, as the risks outweigh the potential rewards.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.